Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cathedra Bitcoin Announces Conference Schedule for May 2025
-
Climate First Bank Elevates C-Suite Leadership Team With Strategic Promotions
-
BluMetric Announces Master Service Agreement and Initial $5.8M Service Contract for Canadian Department of National Defence's Water Purification Systems
-
Moderna to Present at Upcoming Conferences in June 2025
-
San Albino Royalty Exploration Update Highlighted 39.15 g/t Au over 5.9 m (Estimated True Width) 19.2 m Below Surface at El Golfo Prospect
-
Bora Biologics Expands San Diego Facility for 2000L+ Scale Biologics Manufacturing, Boosts CDMO Capacity
-
Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
-
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
-
Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Pop
-
BioCryst to Present at Upcoming Investor Conferences
-
Emerita Achieves 81.5% Gold Recovery for 27% Improvement Over Previous Metallurgical Testing for IBW Project
-
Transcard Partners with Thredd to Accelerate Global Expansion
-
Q2 Metals Expands Major Lithium Zone at the Cisco Lithium Project: Hole 27 Drilled 179.6 Metres at 1.66% Li₂O, 58.0 Metres at 1.75% Li₂O, and 91.8 Metres at 1.81% Li₂O
-
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration
-
Fury Announces C$4.3M Strategic Investment
-
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials
-
GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
-
Xtract One Teams Up with MLB’s Colorado Rockies to Deploy SmartGateway at Coors Field, Bringing Frictionless Screening to Fans this Season
-
Ituran Announces New OEM Agreement with Stellantis in South America
-
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
-
Europe's chemical recycling requires over €400 billion in cumulative capex to compete with virgin plastics production - who will lead?
-
Telycam Launches Explore XE 4K PTZ Camera with 1-Inch Sensor for Broadcast AV
-
BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
-
MEXC Announces the Listing of Sophon (SOPH) with $40,000 in SOPH and 50,000 USDT Prize Pool
-
Grounded Lithium Reports First Quarter 2025 Financial and Operating Results
-
Uranium Energy Corp Applauds Trump Administration's Transformational Executive Orders to Quadruple U.S. Nuclear Capacity and Rebuild Domestic Uranium Fuel Cycle
-
IsoEnergy Advances U.S. Uranium Mines Toward Potential Production
-
Serco Completes Acquisition of Northrop Grumman’s Mission Training & Satellite Ground Network Communications Software Business
-
IgniteTech Acquires Khoros to Transform Customer Connections in the AI Answer Engine Era
-
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
-
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
ReposiTrak Adds 60 New Grocery Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
-
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
-
Champion Homes Announces Definitive Agreement to Acquire Iseman Homes, Inc.
-
SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection
-
Littelfuse Names Abhi Khandelwal Chief Financial Officer
-
Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference
-
Champion Homes Announces Fourth Quarter and Full Year Fiscal 2025 Results
-
QXO Announces Five Finalists for Female Roofing Professional of the Year
-
Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
-
QXO Announces Five Female Roofing Professional of the Year Finalists
-
LLCP Names Michael Weinberg and Matthew Frankel as Co-Chairs of Investment Committee
-
DoorDash Announces Proposed Private Offering of $2.0 Billion of Convertible Senior Notes
-
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
-
Dine Brands Global, Inc. Announces Intention to Refinance Its Series 2019-1 Class A-2-II Fixed Rate Senior Secured Notes and Its Series 2022-1 Class A-1 Variable Funding Senior Notes Through a Securit
-
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
-
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
-
Radical Transparency Bears Fruit: California Olive Ranch Earns Seed Oil Free Certification
-
BBT.live Selected to Present Its Secure Connectivity Platform as Part of the Israeli Delegation at VivaTech Paris 2025, as awarded startup
-
U.S. Department of the Interior Greenlights Anfield’s Velvet-Wood Uranium-Vanadium Mine
